Selected article for: "antiviral drug and drug hydroxychloroquine"
Author: Elkholy, Karim O; Hegazy, Omar; Erdinc, Burak; Abowali, Hesham
Title: Ivermectin: A Closer Look at a Potential Remedy
  • Cord-id: bgj0dmiy
  • Document date: 2020_9_11
    • ID: bgj0dmiy
    Snippet: Amid the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, the search for effective treatment and vaccines has been exponentially on the rise. Finding effective treatment has been the core of attention of many scientific reports and antivirals are in the center of those treatments. Numerous antivirals are being studied for the management of the coronavirus disease 2019 (COVID-19) pneumonia caused by the SARS-CoV-2. Remdesivir was the first drug to gain emergency FDA approval
    Document: Amid the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, the search for effective treatment and vaccines has been exponentially on the rise. Finding effective treatment has been the core of attention of many scientific reports and antivirals are in the center of those treatments. Numerous antivirals are being studied for the management of the coronavirus disease 2019 (COVID-19) pneumonia caused by the SARS-CoV-2. Remdesivir was the first drug to gain emergency FDA approval to be used in COVID-19. Similarly, favipiravir, an anti-influenza drug, is being studied as a potential agent against COVID-19. Contrastingly, hydroxychloroquine has been a controversial drug in the management of COVID-19. Nevertheless, the National Institute of Health (NIH), along with the World Health Organization (WHO), have discontinued clinical trials for hydroxychloroquine as the drug showed little or no survival benefit. Ivermectin, an antihelminthic drug, has shown antiviral properties previously. Additionally, it was described to be effective in vivo against the SARS-CoV-2. However, its survival benefit in patients with COVID-19 has not been documented. We herein propose the theory of inhaled ivermectin which can attain the desired lung concentration that will render it effective against SARS-CoV-2.

    Search related documents:
    Co phrase search for related documents
    • action antiviral mechanism and lung tissue: 1, 2
    • action likely mechanism and acute sars cov respiratory syndrome coronavirus: 1
    • action likely mechanism and lung tissue: 1
    • acute sars cov respiratory syndrome coronavirus and lopinavir hydroxychloroquine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and lung concentration: 1, 2, 3, 4, 5, 6
    • acute sars cov respiratory syndrome coronavirus and lung fluid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute sars cov respiratory syndrome coronavirus and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and macrophage clearance: 1
    • lopinavir hydroxychloroquine and low mortality: 1, 2, 3
    • lopinavir hydroxychloroquine and lung concentration: 1
    • lopinavir hydroxychloroquine and lung tissue: 1, 2, 3, 4, 5
    • low mortality and lung concentration: 1
    • low mortality and lung fluid: 1
    • low mortality and lung tissue: 1
    • low mortality and lymphatic filariasis: 1, 2